≡ Menu

Modern Fertility Launches its First Home Fertility Kit

In an attempt to revolutionize the Femtech market and encourage women to think more about their health, Modern Fertility has come up with an at-home fertility kit. The product is the first from its kitty since the startup, based out of SFO, was established two years ago. Through the launch, the company intends to provide an easily-accessible and comfortably affordable fertility test to its women audience.  

The kit costing $159 would enable women to test their hormone levels at home. They can then consult a doctor who would review their blood sample and provide a detailed report explaining as to how these hormones work in relation to the ovarian reserve, egg freezing, menopause, and other stages in a woman’s reproductive cycle. This, in turn, can help women understand their bodies better and even plan their families accordingly.

The subject of women fertility has long been enveloped in dense layers of ignorance. Women seldom have tried to understand this very important part of their life cycle – fertility. This home fertility kit by Modern Fertility is an endeavor in this direction.

Said Afton Vechery, co-founder, Modern Fertility, “We built Modern Fertility by listening to women and understanding what they want. We don’t push women toward fertility treatments and we don’t prescribe a pill. Our product is designed to fill the biggest information gap in women’s health.”

Further to this motive, the company stated that it has been making efforts in the recent past to provide accurate medical information on woman fertility so as to offer a more transparent picture on the subject.

Moreover, Vecheryin a recent announcement declared that the company has raised $15 million in a round that was led by Forerunner Ventures. He also said that the latter’s founding partner Kirsten Greens will soon be joining Modern Fertility’s board. Vechery also said that the capital raised is expected to help grow the team, facilitate advancements in scientific research, and also enable the development of new similar products in the broader domain of woman reproductive health.

View all contributions by

I am Christopher Roberts and I’m passionate about business and finance news with over 7 years in the industry starting as a writer working my way up into senior positions. I am the driving force behind www.analystsmedia.com with a vision to broaden the company’s readership throughout 2015. Address: 3897 Logan Lane, Denver, CO 80202 Email: Christopher@analystsmedia.com Contact Number: (1) 303-285-1981